Blau syndrome: genes and variants
Explore variant evidence for Blau syndrome across 1 analyzed protein (NOD2). Linked ClinVar records include 12 pathogenic or likely pathogenic variants, 108 variants of uncertain significance and 33 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Blau syndrome
NOD2: Nucleotide-binding oligomerization domain-containing protein 2
It detects bacterial muramyl dipeptide in the cytosol and activates antimicrobial and inflammatory responses. Common loss-of-function variants strongly increase Crohn-disease susceptibility, whereas distinct gain-of-function variants cause Blau syndrome.
12 ClinVar pathogenic / likely pathogenic and 141 uncertain variants in NOD2 have source records linked to Blau syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Blau syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NOD2 R334Q | 334 | NACHT | Pathogenic / likely pathogenic (★★) |
| NOD2 R334W | 334 | NACHT | Pathogenic / likely pathogenic (★★) |
| NOD2 N670K | 670 | Pathogenic / likely pathogenic (★★) | |
| NOD2 M513T | 513 | NACHT | Pathogenic / likely pathogenic (★★) |
| NOD2 R587C | 587 | NACHT | Pathogenic / likely pathogenic (★★) |
| NOD2 E383D | 383 | NACHT | Pathogenic / likely pathogenic (★) |
| NOD2 E383K | 383 | NACHT | Pathogenic / likely pathogenic (★) |
| NOD2 D382E | 382 | NACHT | Pathogenic / likely pathogenic (★) |
| NOD2 C495Y | 495 | NACHT | Pathogenic / likely pathogenic (★) |
| NOD2 G481D | 481 | NACHT | Pathogenic / likely pathogenic (★) |
| NOD2 L469F | 469 | NACHT | Pathogenic / likely pathogenic |
| NOD2 H496L | 496 | NACHT | Pathogenic / likely pathogenic |
Which prediction tools work for Blau syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaLR: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 92 out of 100
- PolyPhen-2: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 84 out of 100
- SIFT: 78 out of 100
- ESM1b (LLR): 74 out of 100
Diseases related to Blau syndrome
- Autoinflammatory syndrome, also linked to NOD2
- Crohn disease, also linked to NOD2
- Inflammatory bowel disease, also linked to NOD2
Frequently asked questions
Which genes have records linked to Blau syndrome?
This view contains 1 analyzed proteins: NOD2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 12 pathogenic or likely pathogenic variants, 108 variants of uncertain significance and 33 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 181 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center